General Information |
|
| NSE Symbol* | BETA |
| Name of the Company* | BETA DRUGS LIMITED |
| ISIN* | INE351Y01019 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2025-02-05 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2025-01-30 |
| Details of Trading Window Closure End date | ting-l -Ti |
| Short Notice | |
| Date of Report* | 2025-02-01 |
Agenda Details |
|
| Agenda* |
1) Bonus 2) Other business |
| Whether results are audited or unaudited | |
| Nature of report standalone or consolidated | |
| Period end Type | |
| Period up to (Month) | |
| Period up to (Year) | |
| Mode of raising Funds | |
| Type of Dividend | |
| Remarks (website dissemination) | Other business include Migration of listing / trading of equity shares of the company from Emerge platform of National Stock Exchange of India Limited (NSE) to main board of National Stock Exchange of India Limited as well as on main board of BSE Ltd. |